University of Vermont, 1992

2018 Accomplishments

Dr. Rush has been extremely productive during 2018 in the areas of research, teaching, service, and administration. Dr. Rush is served as the principal investigator on two (2) R01 projects as well as a R56 project from the National Institute on Drug Abuse (NIDA). Dr. Rush is a coinvestigator on at least six (6) other NIH-funded projects, which reflects his collaborative spirit. During 2017, Dr. Rush continued his role as director of a T32 awarded to the University of Kentucky entitled Research Training in Drug Abuse Behavior. Dr. Rush submitted at least two (2) R01 and UG3-UH3 grant applications to the National Institutes on Health (NIH) as principal investigator for consideration for funding. Two of these grants received a good score and are under consideration for funding. Another application was scored but required a revised submission. Dr. Rush is a co-investigator on five (5) applications submitted to NIH by other Behavioral Science faculty during 2018, three (3) of which received very favorable priority scores and are under consideration for funding. This activity attests to his commitment to the development of colleagues. Dr. Rush published two (2) manuscripts during 2018 and has three (3) in press or under review. The Laboratory of Human Behavioral Pharmacology at the University of Kentucky, under the direction of Dr. Rush, continues to be highly visible at national or international scientific meetings with at least eight (2) presentations during 2018. Dr. Rush gave two (2) invited addresses during 2018. Dr. Rush contributed to the teaching mission of the department during 2018. Dr. Rush served as a mentor to a graduate student (Amy L. Meadows, MD, Clinical and Translational Science Program), and two post-doctoral fellows (Joseph L. Alcorn III, PhD; Anna R. Reynolds, PhD). Dr. Rush served on the committee of at least three (3) other graduate students. Dr. Rush continued to serve on the University Appeals Committee and the University Sexual Misconduct Appeals Committee, both of which are Presidential appointments. Dr. Rush continued to serve as a Vice-Chair of a Medical Institutional Review Board (IRB). Dr. Rush continued in his role as an Associate Editor for Drug and Alcohol Dependence and handles approximately 100 manuscripts annually. Dr. Rush provided review services to several other scientific journals. Finally, Dr. Rush continued to serve as the Vice Chair for Research in Psychiatry during 2018.